Application of Mobile DR in the Diagnosis of Bone Trauma in High Cold Environment

NCT ID: NCT05440435

Last Updated: 2022-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-01-01

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In the high cold environment, mobile digital radiography (DR) is used to collect the imaging of bone injury patients, and the artificial intelligence diagnosis module is used to diagnose the injury. The quality of images obtained by mobile or conventional DR and the consistency between artificial intelligence and pure artificial diagnosis will be analyzed respectively. Finally, the application value of mobile DR loaded with artificial intelligence diagnosis function in high cold environment is determined.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bone Injury Artificial Intelligence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Center A

Study center A that observe cohort populations (sample size=400).

digital radiography (DR)

Intervention Type DIAGNOSTIC_TEST

Patients with bone injury received routine and mobile DR sequential examination.

Center B

Study center B that observe cohort populations (sample size=400).

digital radiography (DR)

Intervention Type DIAGNOSTIC_TEST

Patients with bone injury received routine and mobile DR sequential examination.

Center C

Study center C that observe cohort populations (sample size=400).

digital radiography (DR)

Intervention Type DIAGNOSTIC_TEST

Patients with bone injury received routine and mobile DR sequential examination.

Center D

Study center D that observe cohort populations (sample size=400).

digital radiography (DR)

Intervention Type DIAGNOSTIC_TEST

Patients with bone injury received routine and mobile DR sequential examination.

Center E

Study center E that observe cohort populations (sample size=400).

digital radiography (DR)

Intervention Type DIAGNOSTIC_TEST

Patients with bone injury received routine and mobile DR sequential examination.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

digital radiography (DR)

Patients with bone injury received routine and mobile DR sequential examination.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with new bone injury

Exclusion Criteria

* Life threatening.
* Head injury and fracture.
* There are congenital malformations in the bone injury site.
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rongrong Hua

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rongrong Hua

Principal Investigator

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Guisheng Wang, Doctor

Role: STUDY_CHAIR

Third center of PLA General Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Center A

Beijing, Beijing Municipality, China

Site Status RECRUITING

Xucheng He

Neimeng, , China

Site Status RECRUITING

Center C

Xinjiang, , China

Site Status RECRUITING

Center

Xizang, , China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Rongrong Hua, Doctor

Role: CONTACT

0086-15810159356

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Rongrong Hua, Dr.

Role: primary

+8615810159356

Xucheng He

Role: primary

Xucheng He

Role: primary

Xucheng He

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DR001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.